MedCity News January 21, 2026
Marissa Plescia

NIH-backed startup Amissa has launched an AI-powered platform that aggregates data from multiple sources to improve how menopause and perimenopause are tracked and treated.

Amissa, a startup backed by the National Institutes of Health, launched on Wednesday to improve menopause care with its AI-powered platform.

The Charlotte, North Carolina-based company is a recipient of the NIH’s Small Business Innovation Research grant. Amissa uses data from multiple sources to generate insights that help clinicians track changes in menopause symptoms over time and make more informed care decisions. It uses three main pillars of data, according to Samantha Smith, co-founder and CEO of Amissa:

  • The Menopause Rating Scale: a questionnaire that assesses the severity of common menopausal symptoms like hot flashes,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Provider, Technology
Related Articles:
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs
Daniel Kraft: “The future of healthcare depends on our mindset”
Yann LeCun On Artificial General Intelligence And The Digital Commons
Anthropic closes latest funding round above $10 billion and could go higher, sources say

Share Article